| http://www.w3.org/ns/prov#value | - At KineMed, Doyle will lead corporate development activities including licensing and strategic partnerships to enable the Company's vision of changing the way decisions are made in healthcare and wellness through the application of its proprietary kinetic proteomics platform and to expand on its legacy of collaborative pharmaceutical relationships to also establish its own pipeline of therapeutic
|
